Hi everyone! In coordination with the dermatology interest groups at Georgetown, GW, and Howard, I will be hosting a doubles tennis tournament to raise awareness/money for IMPACT Melanoma. If you are in the D.C. area on Saturday May 20th please sign up! #dermtwitter #MedTwitter

This Saturday I hosted the IMPACT Melanoma D.C Serve your skin tennis tournament. We had great turnout with 45+ attendees/volunteers and raised over $10,500 among the medical schools. Special thanks to Melanoma Research Foundation for donating educational materials! #MedTwitter #dermtwitter

What a week! Finished my summer research program in NYC at the Medical Student Training in Aging Research @ ISMMS and three of my abstracts were accepted to Society For Melanoma Research conference! Thank you to my mentors Dr. Chipuk and Dr. Gulati Mount Sinai Dermatology for hosting me. Look forward to coming back!#dermtwitter #MedTwitter

Honored that my abstract was accepted for a poster and oral presentation at the SJS/TEN: Bringing Science to All Conference! Very excited to learn from leaders in the field: Helena B. Pasieka, MD, MS, Robert Micheletti, Hajirah Saeed, and Elizabeth J. Phillips. #dermtwitter #MedTwitter

Honored to be included in the The Tisch Cancer Institute September newsletter, highlighting my summer melanoma research with the Mount Sinai Dermatology department! #MedTwltter #dermtwitter

Grateful for the opportunity to share exciting results on our community impact from the first year of the #ServeYourSkin skin cancer prevention initiative! #SMR #Skincancerprevention

A very eventful week! I had the opportunity to present two posters Society For Melanoma Research in Philadelphia and win best poster presentation Virginia Dermatology Society in Virginia Beach. Thank you to Dr. Gulati Mount Sinai Dermatology and Dr. Al-Mondhiry Inova for mentoring! #MedTwitter #dermtwitter

Many congrats to Sach Thakker for winning Best Poster at the #VDS 2023 conference this wknd! Sharing some of our great work integrating #Immunotherapy into the care of pts w/locally advanced cSCC. The images are striking but such CRs are *utterly common* in this disease (>60%)

Excited to annouce I have been awarded the Melanoma Research Foundation (MRF) Medical Student Research Grant! I look forward to continuing my collaboration with Mount Sinai Dermatology. Special thanks to Melanoma Research Foundation and my mentor Dr. Jerry Chipuk! #medtwitter #dermtwitter

Had an amazing time rotating at the department of dermatology Johns Hopkins Medicine for the past couple of weeks! Thank you to my mentor Dr. Jun Kang and the Skin of Color society for giving me this opportunity through their observership program/grant! #MedTwitter #dermtwitter

Complete Resolution of Bulky Cutaneous Squamous Cell Carcinoma by Programmed Death-1 Inhibitor. Full text of this image case report from Sach Thakker Georgetown Medicine Inova Schar Cancer Institute UVA School of Medicine is freely available at ow.ly/QTAa50QN6Oc

My first #AAD was such an amazing experience! I had the opportunity to give three oral presentations on HS-cSCC, DHR, and melanoma disparities. Grateful for the new friends I made. Look forward to coming back next year! #AAD2024 #medtwitter

Out now in JAAD Journals! We show clinical images of Merkel Cell Carcinoma in a variety of stages, anatomical locations, and skin types. Thanks to Jafar Al-Mondhiry, MD, MA for being the PI and the wonderful derm-onc team Inova. #MedTwitter #dermtwitter sciencedirect.com/science/articl…

The USMLE Step 1 change to a pass/fail system has reshaped the landscape for evaluating residency applications. 👉 Check out this insightful manuscript for a deeper dive into navigating these ethical and evaluative challenges. #MedTwitter #dermtwitter jaad.org/article/S0190-…

Out now in JAAD Journals! What is the purpose of board certification and do alternative certifying bodies have the same standards? Check out our new manuscript looking into the ethics of this manner! #medtwitter #dermtwitter jaad.org/article/S0190-…

Happy to showcase some of our results managing LA cSCC with PD-1 inhibitor mono-therapy: Among 54 pts w/ large (>2cm) tumors Inova Schar Cancer Institute, we found an ORR 74% (CR 54%, PR 20%) t/w a median of 4 infusions & manageable safety profile (any grade irAE 20%). jaadinternational.org/article/S2666-…

Thrilled to share our new manuscript in JAAD Journals. We explore how #PreferenceSignaling impacts fairness, mentorship & equity in #DermResidency. Check it out: jaad.org/article/S0190-… #DermTwitter #MedEd #Ethics #ResidencyMatch

#AAD2025 is a wrap! What a wonderful experience meeting mentors and friends! Had the opportunity to present two abstracts, one of which was selected as a top 20 finalist. Look forward to seeing everyone next year! #dermtwitter

This study on NIVO-RELA in advanced melanoma found an ORR of 39% & median PFS of 5.3 months. Notably, 1L treatment had an ORR of 58% & median PFS of 11 months. Promising real-world results! #Melanoma #Oncology Sach Thakker Jafar Al-Mondhiry, MD, MA Inova Schar Cancer Institute doi.org/10.1093/oncolo…